지투지바이오

456160KOSDAQ의약품 제조업

50.7 / 100

Reference Date: 2026-07-24

Financial Score17.5 / 40

News Sentiment20.2 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PBR raises overvaluation concerns. Plunged 25.4% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

GTJ Bio is a leading company in microsphere technology for prolonged-release pharmaceuticals, utilizing its InnoLAMP platform to develop drugs for various diseases and offering CDO/CDMO services. Its key products, including GB-7001, GB-5001, and GB-6002, are undergoing clinical trials in collaboration with global pharmaceutical companies, supported by patented technology and large-scale production capabilities that create high entry barriers.

Number of Employees

48people

Average Salary

125.4M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 11.234.0Point

PBR

8.64Industry Average 0.810.0Point

10.7x industry avg (risky)

ROE

—Industry Average 4.013.5Point

Debt Ratio

3.69Industry Average 12.438.0Point

Half of industry avg (excellent)

Trend 2024~20252.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼45.0% (1-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼13.4% (1-year basis)

ROE Trend

2.0 / 4

Detailed News Sentiment

8 totalPositive 7Neutral 1Negative 0Average Sentiment Score 80.6

Positive
지투지바이오, 스파이더코어와 맞손… 장기지속 주사제 연구에 AI 접목
지투지바이오가 AI 기술 도입을 통해 장기지속 주사제 연구에 혁신을 추구하며 파트너십을 강화함으로써 긍정적인 시장 반응을 기대.
Positive
지투지바이오, 장기지속형 주사제 개발에 AI 도입...R&D 속도 높...
지투지바이오가 AI 기술 도입으로 장기지속형 주사제 개발 속도를 가속화하여 긍정적인 시장 반응을 기대.
Positive
지투지바이오, AAIC서 월 1회 치매치료제 임상 1상 데이터 공개
지투지바이오의 알츠하이머 치료제 GB-5001 임상 데이터 공개로 긍정적인 시장 반응 예상.

Detailed Momentum

52-week position1.0Point

Near 52w low (2%, downtrend)

Current 30,300Won52-week high 118,80052-week low 28,150

1-month return0.0Point

1m -25.37% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral기업설명회(IR)개최2026-07-01